Doctors Note Logo

Published on: 10/1/2026

What the HPV vaccine is, how many doses and at what ages

The HPV vaccine (Gardasil 9 in the U.S.) protects against the human papillomavirus strains that cause most cervical, anal, throat, penile, vulvar, and vaginal cancers, as well as genital warts. Routine vaccination is recommended at ages 11 to 12, though it can start as early as age 9, and catch-up doses are advised through age 26 for anyone not already fully vaccinated. Those who start the series before their 15th birthday need only two doses given 6 to 12 months apart, while anyone starting at 15 or older, or who is immunocompromised, needs three doses over six months. Adults ages 27 to 45 may still benefit in some cases, and timing, spacing, and eligibility details matter, so see the complete answer below before deciding.

If you have questions about HPV exposure, genital warts, abnormal Pap results, or whether vaccination still makes sense for you, a few minutes of self-assessment can bring real clarity; take a free, instant, online symptom check to understand what your symptoms may mean and what to discuss with your doctor next.

Last reviewed for medical accuracy: 10/01/2025

answer background

Explanation

What Is HPV Vaccine and Why It Matters

Human papillomavirus (HPV) is a common viral infection spread through intimate skin-to-skin contact. While most HPV infections clear on their own, some strains can lead to genital warts and certain cancers (cervical, anal, penile, throat). The HPV vaccine is a powerful tool in preventing these health risks—and understanding what is HPV vaccine, how many doses you need, and at what ages is key to making informed decisions about your health.

What Is HPV Vaccine?

The HPV vaccine is a preventive immunization designed to protect against the most common cancer-causing and wart-causing strains of human papillomavirus. There are currently two main vaccines in widespread use:

  • Gardasil 9
    • Covers nine HPV strains (including types 16 and 18, responsible for the majority of HPV-related cancers, and types 6 and 11, which cause most genital warts).
    • Recommended by public health authorities worldwide.

How it works:

  1. The vaccine introduces harmless virus-like particles (VLPs) that mimic the HPV outer shell without containing viral DNA.
  2. Your immune system recognizes these particles and builds antibodies.
  3. If you’re later exposed to real HPV, your body can neutralize the virus before it causes infection or abnormal cell changes.

Who Should Get the HPV Vaccine?

Following guidelines from leading health organizations like the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO), these groups are recommended to receive the HPV vaccine:

  • Preteens (Ages 11–12)
    • Ideal timing: before any potential exposure to HPV through intimate contact.
  • Children (Ages 9–10)
    • May receive the vaccine if in high-risk groups or at the provider’s discretion.
  • Teens and Young Adults (Ages 13–26)
    • Catch-up vaccination is advised if not fully vaccinated at younger ages.
  • Adults (Ages 27–45)
    • May consider vaccination based on individual risk factors and shared decision-making with a healthcare provider.

How Many Doses and at What Ages?

The number of HPV vaccine doses you need depends on the age at which you start the series:

  • Started Before 15th Birthday
    • 2 doses:
      • First dose at chosen date.
      • Second dose 6–12 months later.
  • Started On or After 15th Birthday
    • 3 doses:
      1. First dose at chosen date.
      2. Second dose 1–2 months after the first.
      3. Third dose 6 months after the first.
  • Adults Up to 45 Years
    • Follow the 3-dose schedule if unvaccinated or incompletely vaccinated.

Benefits of the HPV Vaccine

  • Reduces the risk of developing HPV-related cancers by up to 90%.
  • Prevents most genital warts caused by vaccine-covered HPV strains.
  • Creates herd immunity—lowering HPV circulation in the community.
  • Long-lasting protection: studies show strong immune response for at least a decade, with ongoing monitoring.

Safety and Side Effects

HPV vaccines have been rigorously tested in clinical trials and monitored in millions of people worldwide. Common side effects are mild and short-lived:

  • Injection Site Reactions
    • Soreness, redness or swelling where the shot was given.
  • Systemic Symptoms
    • Low-grade fever, headache, fatigue.
  • Less Common
    • Dizziness or fainting (especially in adolescents; recommended to sit or lie down for 15 minutes after vaccination).

Serious allergic reactions are very rare. If you have a history of severe allergies to any vaccine component, discuss this with your healthcare provider.

When to Talk to a Doctor

Before getting the HPV vaccine, let your provider know if you:

  • Are pregnant or planning pregnancy.
  • Have a weakened immune system (due to disease or medication).
  • Have had any serious allergic reaction to a previous dose.
  • Currently have an acute moderate or severe illness (you may be advised to wait).

If you experience any symptoms that worry you—such as high fever, severe headache, difficulty breathing, or signs of serious allergic reaction—seek medical attention right away. You can also start with a free, online symptom check, using the doctor approved Ubie Symptom Checker to get guidance on whether you should see a doctor urgently.

Common Questions

Q: Is the HPV vaccine only for girls?
A: No. Both girls and boys benefit from HPV vaccination. It prevents genital warts and many types of cancer in all genders and contributes to broader community protection.

Q: Can you get HPV after vaccination?
A: The vaccine protects against the most common high-risk HPV types but not all of them. Safe practices (condom use, regular screenings) remain important.

Q: What if I missed doses as a teen?
A: It’s never too late to start or complete the series. Follow the age-based dosing schedule and talk to your provider about catch-up options.

Next Steps

  • Check Your Records: Review your vaccination history.
  • Schedule an Appointment: Contact your primary care provider or local health clinic.
  • Prepare for the Visit: Note any health conditions or medications.
  • Complete the Series: Keep track of dose dates to ensure full protection.

If you have any concerns or develop symptoms that feel serious—especially those that could be life threatening—please speak to a doctor right away. A healthcare professional can assess your situation, recommend testing or treatment, and address any urgent health needs.


Getting the HPV vaccine is a safe, effective way to protect yourself and your loved ones from potentially serious infections and cancers. By understanding what is HPV vaccine, following the recommended dosing schedule, and maintaining open communication with your doctor, you take a proactive step toward long-term health. Don’t hesitate to use tools like the free, online symptom check, using the doctor approved Ubie Symptom Checker whenever you need quick guidance—and always consult your healthcare provider for any life-threatening or serious concerns.

(References)

  • * Campos-Outcalt D. ACIP immunization update. J Fam Pract. 2012 Mar;61(3):150-2. PMID: 22393553.

  • * Sanderson K. Vaccination: A durable design. Nature. 2012 Aug 30;488(7413):S7. doi: 10.1038/488S7a. PMID: 22932439.

  • * Three doses of HPV vaccine still recommended, for now. BMJ. 2013 Apr 30;346:f2797. doi: 10.1136/bmj.f2797. 2013 Apr 30. PMID: 23637199.

  • * USA missing opportunities for HPV vaccination. Lancet Infect Dis. 2013 Sep;13(9):725. doi: 10.1016/S1473-3099(13)70230-5. PMID: 23969206.

  • * Harper DM. Conclusions about the quadrivalent human papillomavirus vaccine efficacy based on alternate dosing schedules and less than three dose immunogenicity is inappropriate. J Infect Dis. 2014 Jul 15;210(2):330-1. doi: 10.1093/infdis/jiu072. 2014 Feb 5. PMID: 24501212.

  • * Fessler B. [Two-dose vaccination schedule for younger girls]. Med Monatsschr Pharm. 2014 May;37(5):189-90. PMID: 24908937.

  • * Brotherton JM, Winch K. The effect of making a 'third dose assumption' on HPV coverage estimates. Aust N Z J Public Health. 2015 Apr;39(2):193-4. doi: 10.1111/1753-6405.12320. 2015 Jan 5. PMID: 25559458.

  • * Campos-Outcalt D. Immunization update: This year's changes. J Fam Pract. 2016 Mar;65(3):198-200. PMID: 27158692.

  • * Moreno MA. Human Papillomavirus Vaccination. JAMA Pediatr. 2019 Feb 1;173(2):204. doi: 10.1001/jamapediatrics.2018.4546. PMID: 30715165.

  • * Meites E, Szilagyi PG, Chesson HW, Unger ER, Romero JR, Markowitz LE. Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2019 Aug 16;68(32):698-702. doi: 10.15585/mmwr.mm6832a3. 2019 Aug 16. PMID: 31415491; PMCID: PMC6818701.

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.